← Back to Search

Use of Purposeful app for Ovarian Cancer

N/A
Waitlist Available
Led By Celeste Leigh Pearce, PhD, MPH
Research Sponsored by University of Michigan Rogel Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights

Study Summary

This trial will follow ovarian cancer survivors for six months to see if an eHealth app called "Purposeful" is helpful to them.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Acceptability assessed by percentage of patients who find the Purposeful app to be acceptable
Feasibility assessed by enrollment rate
Feasibility assessed by percentage of days of app use
+1 more
Secondary outcome measures
Change in life purpose from baseline
Change in quality of life assessed using Functional Assessment of Cancer Therapy-Ovarian (FACT-O) Trial Outcome Index (TOI) (FACT-O TOI)
Change in quality of life assessed using Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-F)
+1 more

Trial Design

3Treatment groups
Experimental Treatment
Group I: Recurrence of ovarian cancerExperimental Treatment1 Intervention
25 women who have experienced a recurrence of their ovarian cancer after primary treatment
Group II: Recently completed treatmentExperimental Treatment1 Intervention
25 women who have just completed treatment
Group III: No recurrence of ovarian cancer for at least one yearExperimental Treatment1 Intervention
25 women who have not experienced a recurrence of their ovarian cancer at least one year after their initial diagnosis
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Use of Purposeful app
2021
N/A
~60

Find a Location

Who is running the clinical trial?

University of Michigan Rogel Cancer CenterLead Sponsor
294 Previous Clinical Trials
24,061 Total Patients Enrolled
4 Trials studying Ovarian Cancer
1,127 Patients Enrolled for Ovarian Cancer
Rogel Cancer Center Cancer Control and Population Sciences O-SURE initiativeUNKNOWN
Celeste Leigh Pearce, PhD, MPHPrincipal InvestigatorUniversity of Michigan

Media Library

Purposeful app Clinical Trial Eligibility Overview. Trial Name: NCT04458168 — N/A
Ovarian Cancer Research Study Groups: Recurrence of ovarian cancer, Recently completed treatment, No recurrence of ovarian cancer for at least one year
Ovarian Cancer Clinical Trial 2023: Purposeful app Highlights & Side Effects. Trial Name: NCT04458168 — N/A
Purposeful app 2023 Treatment Timeline for Medical Study. Trial Name: NCT04458168 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What outcomes is this medical experiment hoping to realize?

"This clinical trial will primarily assess the feasibility of a given medication by measuring the percentage of days it is used. Secondary outcomes include changes to quality of life which are measured using three different questionnaires; Functional Assessment of Cancer Therapy-Ovarian (FACT-O) Trial Outcome Index (TOI), Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-F), and Comprehensive Measure of Meaning (Wellbeing Questionnaire Part 10). Each questionnaire uses either 5 or 7 point Likert Scales, with higher scores indicating an improved quality/state for each patient."

Answered by AI

Are there any current opportunities to join this clinical investigation?

"The clinical trial, which was published on June 28th 2021 and last updated October 6th 2022 according to the information hosted on clinicaltrials.gov is no longer looking for participants. However, at present there are 398 other active enrolment studies that require volunteers."

Answered by AI
~16 spots leftby Apr 2025